Thus, the present Tfam KO mice provide a good model for studies of mechanisms underlying muscle defects at different stages of mitochondrial myopathies, and the knowledge gained can be used to propose novel treatment strategies for these serious diseases for which no effective treatment currently exists. The gene discussed is TFAM; the disease is Mitochondrial myopathy.